Low levels of LDL cholesterol reduce the risk of cardiovascular disease and events. However, is it safe to reduce LDL cholesterol levels that are already low? A new study investigates.
James A. Underberg, MD, outlined recent cardiovascular outcomes evidence for PCSK9 inhibitors and discussed strategies for improving access to therapy for appropriate patients.
In a recent report, the CDC sought to establish a baseline for the CVD risk factors targeted for reduction by the Million Hearts 2022 initiative during 2017–2021 and highlights recent changes over time.
...
After noting that only modest benefits have been seen in long-term CVD prevention with aspirin, researchers examined whether bodyweight leading to misdosing could explain these results.
The USPSTF has updated its 2009 recommendations on the use of nontraditional risk factors in assessment of coronary heart disease risk, focusing on 3 risk factors.
The USPSTF has updated its 2009 recommendations on the use of nontraditional risk factors in assessment of coronary heart disease risk, focusing on 3 risk factors.
Multivitamin use is widespread around the world, believed to improve health and lower cardiovascular disease risk. However, existing evidence is conflicting. A new analysis investigates.
Researchers assessed the connection, if any, between vitamin K2 deficiency and arterial stiffness in untreated adult migraineurs compared with age- and sex-matched control participants.
Binge drinking is highest among young adults, but the cardiovascular effects of binge drinking are unknown in this population. Investigators examined these effects, in the context of age and sex, in a new...
Patients with heart failure have a reduced quality of life and experience significant physical and social limitations. This analysis of a large study evaluated the effect of a combo drug for HF in improving...
